Duodenal ulcer haemorrhage

Duodenal ulcer haemorrhage is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Duodenal Ulcer Bleeding · Bleeding Duodenal Ulcer
Classified under: Cardiovascular Diseases
Chemically-Induced Disorders
Clinical Procedures, Devices, and Diagnostic Activities
Digestive System Diseases
Disease and Non-Disease Concepts, Unclassified
Signs, Symptoms, and General Pathologies
Indicated drugs: Somatostatin

Resolves to

Vocabularies

SNOMED CT196674000MedDRA10005109UMLSC0151966

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

1Clinical trialPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Duodenal ulcer haemorrhage share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.